| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, September 2007, p. 9268-9278, Vol. 81, No. 17
0022-538X/07/$08.00+0 doi:10.1128/JVI.00650-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Dimitra Zotos,3,4,¶
Kim Wilson,3
Catherine Chatfield,2,
Victoria A. Lawson,2,
Dominic E. Dwyer,5
Anthony Cunningham,5
Jennifer Learmont,6
Wayne Dyer,6
John Sullivan,6
Melissa Churchill,2
Steven L. Wesselingh,2,7
Dana Gabuzda,8,9
Paul R. Gorry,2,7,8 and
Dale A. McPhee1,2,3*
Department of Microbiology, Monash University, Clayton, Victoria, Australia,1 Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia,2 National Serology Reference Laboratory Australia, St Vincent's Institute, Fitzroy, Victoria, Australia,3 School of Biological and Chemical Sciences, Deakin University, Burwood, Victoria, Australia,4 Centre for Virus Research, Westmead Millenium Institute, Westmead, New South Wales, Australia,5 Australian Red Cross Blood Service, Sydney, New South Wales, Australia,6 Department of Medicine, Monash University, Melbourne, Victoria, Australia,7 Dana-Farber Cancer Institute, Boston, Massachusetts,8 Department of Neurology, Harvard Medical School, Boston, Massachusetts9
Received 27 March 2007/ Accepted 6 June 2007
The Sydney Blood Bank Cohort (SBBC) consists of eight blood transfusion recipients infected with nef-attenuated human immunodeficiency virus type 1 (HIV-1) acquired from a single donor. Here, we show that viral phenotypes and antibody responses differ considerably between individual cohort members, despite the single source of infection. Replication of isolated virus varied from barely detectable to similar to that of the wild-type virus, and virus isolated from five SBBC members showed coreceptor usage signatures unique to each individual. Higher viral loads and stronger neutralizing antibody responses were associated with better-replicating viral strains, and detectable viral replication was essential for the development of strong and sustained humoral immune responses. Despite the presence of strong neutralizing antibodies in a number of SBBC members, disease progression was not prevented, and each cohort member studied displayed a unique outcome of infection with nef-attenuated HIV-1.
Published ahead of print on 13 June 2007.
Current address: CSL Ltd., Parkville, Victoria, Australia.
¶ Current address: Walter and Eliza Hall Institute, Parkville, Victoria, Australia.
Current address: Department of Pathology, University of Melbourne, Victoria, Australia.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|